Headed by molecular neuroscientist Randy Blakely, Ph.D., FAU's Brain Institute is commemorating "Brain Awareness Week" (March 13-19) to promote the public and personal benefits of brain research.
About the size of a tablet, a portable device that could be used in many settings like an airport, may hold the key to detecting the Zika virus accurately, rapidly and inexpensively using just a saliva sample.
A compound extracted from a deep-water marine sponge is showing potent antibacterial activity against the drug resistant bacteria methicillin-resistant Staphylococcus aureus also called the "super bug."
Researchers from FAU and Sancilio and Company, Inc. are collaborating to develop a treatment for Retinitis Pigmentosa, an inherited disease that causes severe progressive vision impairment and blindness.
Researchers from FAU and Harvard address the possible but unproven link between statins and diabetes and emphasize that the link to diabetes is questionable and inconsequential.
The first study to examine the effects of chair yoga on pain and physical function in older adults with osteoarthritis is proving to be an effective way to reduce pain and improve quality of life.
A new study at FAU is the first to demonstrate that the Parkin gene is turned on when cells are exposed to environmental insults that cause free radical formation and cataract formation.
Janet Robishaw, Ph.D., a leader in functional and translational genomics, has been appointed as chair of the Department of Biomedical Sciences in FAU's Charles E. Schmidt College of Medicine.
FAU's Schmidt College of Medicine's advisory board member and donor Jack Laub was recently inducted into the James P. Kelly University of Cincinnati Athletics Hall of Fame and the Brooklyn Jewish Hall of Fame.
FAU Harbor Branch scientists are researching ways to create a biosynthetic version of a compound found in a sea sponge that is very active against cancer cells.